Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey
Detection Principle
ImmunoAssay-Antibody
Target
IgM and IgG
Testing Method Category
LFIA
Testing Method
Guangzhou Wondfo Biotech (Guangzhou, China) SARS- CoV-2 Antibody test (lateral flow method); Menarini (Orientgene) Zhejiang Orient Gene Biotech Co Ltd REF; BIOPANDA COVID-19 Rapid Ab test Product Number: RAPG- COV-019 Separate IgM and IgG Target: S and N proteins Fortress Diagnostics COVID- 19 TOTAL Ab Device Product Code: COVID010 / COVID020 Separate IgM and IgG Target antigen: S protein and N protein; BIOPANDA COVID-19 Rapid Ab test Product Number: RAPG- COV-019 Separate IgM and IgG Target: S and N proteins; BIOSURE (Mologic)* COVID-19 Self-Test IgG only Target: N protein
Testing Method - Additional Info
Comparison of 5 commercially available kit
Reported Performance
Specificity: 98.6%; Sensitivity: 84%;
Sample Size
276 patients
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements